Parnell Pharmaceuticals is Helping Your Dogs Lead Happier Lives

Parnell is focused on delivering innovative solutions to unmet animal health needs in the 70 billion dollar pet market.

We have core competences in drug discovery and development, regulatory filings, we have our own FDA approved manufacturing facility and we have a significant commercial presence in 14 countries.

Zydax is our lead compound that we’ve been marketing in Australia Zydax effectively regenerates cartilage and can literally save lives.

We’ve had one of our sales executives tell us a story of seeing a dog in a clinic that just four weeks earlier had been brought in to be euthanized. The pet parents had to carry the dog in, it couldn’t even walk.

After just four injections of Zydax the dog was bouncing around in the clinic, We will soon launch that drug in the United States and also Europe.


Request Investor Kit




Related News

On TV for more than 16 years, BTV-Business Television, a weekly investor program, features emerging companies and top analysts across the US and Canada to bring investors information to grow their portfolio. Hosted by Taylor Thoen, BTV goes on location, interviewing key executives and showcasing their business to give investors insight before they make a buying decision.

Watch BTV
Did you know management is one of the top three reasons why investors buy a stock? Meet the CEO before you invest. CEO Clips are 90 second video profiles on companies in the markets designed to help you make an educated investment decision. According to Forbes, 60% of people prefer watching video over reading text. What are you waiting for? We’ve featured over 1000 companies. Discover a new company now!

Watch CEO Clips
Broadcast On

© 2017 Business Television All Rights Reserved